Abbott

Pharmaceutical firm announces 2005 sales, earnings guidance

Published in Lab Business Week, January 23rd, 2005

Abbott announced 2005 earnings-per-share guidance from continuing operations of $2.47 to $2.53, excluding one-time charges, and 2005 sales growth guidance of 10% to 12%.

The company also confirmed its guidance for earnings per share from Continuing Operations in fourth-quarter 2004 of $0.66 to $0.68, excluding one-time charges.

Abbott expects one-time charges for the full-year 2005 of $0.02 per share. Including these charges, projected earnings per share under Generally Accepted Accounting Principles (GAAP) for full-year 2005 would be $2.45 to $2.51.

Guidance for 2005 does not include the potential impact of proposed new...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-01-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry